brokerage recos sector report
Jump to
3377 Results Found
  • Trent Limited Q4 PAT seen up 1,185.7% YoY to Rs. 33.7 cr: ICICI Direct Apr 13, 2021 12:02 PM IST

    Trent Limited Q4 PAT seen up 1,185.7% YoY to Rs. 33.7 cr: ICICI Direct

    Net Sales are expected to increase by 12 percent Y-o-Y (up 11.6 percent Q-o-Q) to Rs. 809.5 crore, according to ICICI Direct.

  • Titan Company Q4 PAT seen up 68.5% YoY to Rs. 578.2 cr: ICICI Direct Apr 13, 2021 11:57 AM IST

    Titan Company Q4 PAT seen up 68.5% YoY to Rs. 578.2 cr: ICICI Direct

    Net Sales are expected to increase by 58.2 percent Y-o-Y (down 2.2 percent Q-o-Q) to Rs. 7,454 crore, according to ICICI Direct.

  • Bata India Q4 PAT may dip 16.7% YoY to Rs. 31.4 cr: ICICI Direct Apr 13, 2021 11:55 AM IST

    Bata India Q4 PAT may dip 16.7% YoY to Rs. 31.4 cr: ICICI Direct

    Net Sales are expected to decrease by 1 percent Y-o-Y (down 0.2 percent Q-o-Q) to Rs. 613.6 crore, according to ICICI Direct.

  • Avenue Supermarts Q4 PAT seen up 10.9% YoY to Rs. 300.9 cr: ICICI Direct Apr 13, 2021 11:50 AM IST

    Avenue Supermarts Q4 PAT seen up 10.9% YoY to Rs. 300.9 cr: ICICI Direct

    Net Sales are expected to increase by 18.4 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 7,407 crore, according to ICICI Direct.

  • Gland Pharma Q4 PAT seen up 17.3% YoY to Rs. 229 cr: Sharekhan Apr 12, 2021 09:14 PM IST

    Gland Pharma Q4 PAT seen up 17.3% YoY to Rs. 229 cr: Sharekhan

    Net Sales are expected to increase by 30 percent Y-o-Y (down 3.9 percent Q-o-Q) to Rs. 825.8 crore, according to Sharekhan.

  • Solara Active Pharma Q4 PAT seen up 223.6% YoY to Rs. 57.6 cr: Sharekhan Apr 12, 2021 09:14 PM IST

    Solara Active Pharma Q4 PAT seen up 223.6% YoY to Rs. 57.6 cr: Sharekhan

    Net Sales are expected to increase by 35.4 percent Y-o-Y (down 5.8 percent Q-o-Q) to Rs. 401.9 crore, according to Sharekhan.

  • Shilpa Medicare Q4 PAT may dip 72.3% YoY to Rs. 9.6 cr: Sharekhan Apr 12, 2021 09:03 PM IST

    Shilpa Medicare Q4 PAT may dip 72.3% YoY to Rs. 9.6 cr: Sharekhan

    Net Sales are expected to decrease by 15 percent Y-o-Y (down 2.2 percent Q-o-Q) to Rs. 187 crore, according to Sharekhan.

  • Strides Pharma Science Q4 PAT may dip 488.7% YoY to Rs. 72.3 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Strides Pharma Science Q4 PAT may dip 488.7% YoY to Rs. 72.3 cr: Sharekhan

    Net Sales are expected to increase by 31 percent Y-o-Y (down 2.6 percent Q-o-Q) to Rs. 810.3 crore, according to Sharekhan.

  • Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan

    Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.

  • Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan

    Net Sales are expected to increase by 56.6 percent Y-o-Y (up 2 percent Q-o-Q) to Rs. 1,314.3 crore, according to Sharekhan.

  • Granules Q4 PAT seen up 253.6% YoY to Rs. 122.7 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Granules Q4 PAT seen up 253.6% YoY to Rs. 122.7 cr: Sharekhan

    Net Sales are expected to increase by 36.2 percent Y-o-Y (down 3.2 percent Q-o-Q) to Rs. 817.2 crore, according to Sharekhan.

  • Dr Reddy’s Lab Q4 PAT may dip 13.6% YoY to Rs. 674.5 cr: Sharekhan Apr 12, 2021 08:42 PM IST

    Dr Reddy’s Lab Q4 PAT may dip 13.6% YoY to Rs. 674.5 cr: Sharekhan

    Net Sales are expected to increase by 9 percent Y-o-Y (down 1.9 percent Q-o-Q) to Rs. 4,849.3 crore, according to Sharekhan.

  • Biocon Q4 PAT seen up 54.1% YoY to Rs. 203.4 cr: Sharekhan Apr 12, 2021 08:40 PM IST

    Biocon Q4 PAT seen up 54.1% YoY to Rs. 203.4 cr: Sharekhan

    Net Sales are expected to increase by 28.3 percent Y-o-Y (up 8 percent Q-o-Q) to Rs. 1,999.6 crore, according to Sharekhan.

  • Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan Apr 12, 2021 08:40 PM IST

    Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan

    Net Sales are expected to increase by 4.6 percent Y-o-Y (up 1.5 percent Q-o-Q) to Rs. 2,000.7 crore, according to Sharekhan.

  • Sun Pharma Q4 PAT seen up 82.2% YoY to Rs. 1,462.7 cr: Sharekhan Apr 12, 2021 08:40 PM IST

    Sun Pharma Q4 PAT seen up 82.2% YoY to Rs. 1,462.7 cr: Sharekhan

    Net Sales are expected to increase by 6.2 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 8,692.6 crore, according to Sharekhan.

  • LUPIN Q4 PAT seen up 3.5% YoY to Rs. 317.2 cr: Sharekhan Apr 12, 2021 08:40 PM IST

    LUPIN Q4 PAT seen up 3.5% YoY to Rs. 317.2 cr: Sharekhan

    Net Sales are expected to increase by 3.5 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs. 3,979 crore, according to Sharekhan.

  • IPCA Q4 PAT seen up 126.5% YoY to Rs. 194.8 cr: Sharekhan Apr 12, 2021 08:13 PM IST

    IPCA Q4 PAT seen up 126.5% YoY to Rs. 194.8 cr: Sharekhan

    Net Sales are expected to increase by 21.1 percent Y-o-Y (down 7.8 percent Q-o-Q) to Rs. 1,300 crore, according to Sharekhan.

  • Divis Q4 PAT seen up 41.1% YoY to Rs. 467.2 cr: Sharekhan Apr 12, 2021 08:12 PM IST

    Divis Q4 PAT seen up 41.1% YoY to Rs. 467.2 cr: Sharekhan

    Net Sales are expected to increase by 20.9 percent Y-o-Y (down 1.3 percent Q-o-Q) to Rs. 1,680 crore, according to Sharekhan.

  • Cipla Q4 PAT seen up 147.8% YoY to Rs. 609 cr: Sharekhan Apr 12, 2021 08:12 PM IST

    Cipla Q4 PAT seen up 147.8% YoY to Rs. 609 cr: Sharekhan

    Net Sales are expected to increase by 15 percent Y-o-Y (down 2.7 percent Q-o-Q) to Rs. 5,031.7 crore, according to Sharekhan.

  • Cadila Q4 PAT seen up 13.7% YoY to Rs. 505 cr: Sharekhan Apr 12, 2021 08:12 PM IST

    Cadila Q4 PAT seen up 13.7% YoY to Rs. 505 cr: Sharekhan

    Net Sales are expected to increase by 2.5 percent Y-o-Y (up 1.3 percent Q-o-Q) to Rs. 3,844 crore, according to Sharekhan.

  • Aurobindo Q4 PAT seen up 6% YoY to Rs. 901 cr: Sharekhan Apr 12, 2021 08:12 PM IST

    Aurobindo Q4 PAT seen up 6% YoY to Rs. 901 cr: Sharekhan

    Net Sales are expected to increase by 8.3 percent Y-o-Y (up 4.8 percent Q-o-Q) to Rs. 6,671.2 crore, according to Sharekhan.

  • Sudarshan Chemicals Q4 PAT seen up 9.6% YoY to Rs. 37 cr: Sharekhan Apr 12, 2021 07:47 PM IST

    Sudarshan Chemicals Q4 PAT seen up 9.6% YoY to Rs. 37 cr: Sharekhan

    Net Sales are expected to increase by 9.9 percent Y-o-Y (down 2.5 percent Q-o-Q) to Rs. 494 crore, according to Sharekhan.

  • SRF Q4 PAT seen up 38.7% YoY to Rs. 307 cr: Sharekhan Apr 12, 2021 07:47 PM IST

    SRF Q4 PAT seen up 38.7% YoY to Rs. 307 cr: Sharekhan

    Net Sales are expected to increase by 19.6 percent Y-o-Y (down 3.6 percent Q-o-Q) to Rs. 2,223 crore, according to Sharekhan.

  • Atul Q4 PAT seen up 28.7% YoY to Rs. 159 cr: Sharekhan Apr 12, 2021 07:47 PM IST

    Atul Q4 PAT seen up 28.7% YoY to Rs. 159 cr: Sharekhan

    Net Sales are expected to decrease by 0.2 percent Y-o-Y (up 1.2 percent Q-o-Q) to Rs. 964 crore, according to Sharekhan.

  • Aarti Industries Q4 PAT seen up 26.4% YoY to Rs. 160 cr: Sharekhan Apr 12, 2021 07:47 PM IST

    Aarti Industries Q4 PAT seen up 26.4% YoY to Rs. 160 cr: Sharekhan

    Net Sales are expected to increase by 12.5 percent Y-o-Y (up 2 percent Q-o-Q) to Rs. 1,210 crore, according to Sharekhan.

Sections